Table 1. Modeled age-adjusted hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and extrahepatic cholangiocarcinoma incidence rates per 100,000; 2000–2009 by demographic group.
Intrahepatic cholangiocarcinoma | Extrahepatic cholangiocarcinoma | Hepatocellularcarcinoma | ||||
---|---|---|---|---|---|---|
Count | Modeled Rate | Count | Modeled Rate | Count | Modeled Rate | |
Race/Ethnicity a | ||||||
White | 16,069 | 0.84 | 13,589 | 0.69 | 63,712 | 3.22 |
Black | 1,850 | 0.83 | 1,389 | 0.64 | 15,070 | 6.23 |
Hispanic | 2,327 | 1.16 | 1,757 | 0.92 | 18,172 | 8.36 |
Asians/Pacific Islanders | 1,200 | 1.28 | 1,014 | 1.10 | 11,732 | 11.81 |
American Indians/Alaska Natives | 132 | 0.98 | 95 | 0.72 | 954 | 5.92 |
Sex | ||||||
Male | 11,195 | 1.04 | 9,471 | 0.89 | 83,541 | 7.05 |
Female | 10,383 | 0.76 | 8,373 | 0.58 | 26,099 | 1.85 |
Age (Years) | ||||||
0–35 | 243 | 0.03 | 96 | 0.01 | 1,360 | 0.12 |
35–44 | 781 | 0.18 | 440 | 0.09 | 3,544 | 1.18 |
45–54 | 2,676 | 0.80 | 1,487 | 0.43 | 23,741 | 6.24 |
55–64 | 4,668 | 2.04 | 3,143 | 1.37 | 30,803 | 12.39 |
65–74 | 5,715 | 3.63 | 4,751 | 3.05 | 25,757 | 16.62 |
75–84 | 5,485 | 5.14 | 5,546 | 5.00 | 19,912 | 17.39 |
85+ | 2,010 | 5.43 | 2,381 | 5.84 | 4,523 | 11.85 |
Census Division | ||||||
New England | 1,372 | 0.99 | 1,099 | 0.79 | 5,887 | 4.15 |
Middle Atlantic | 4,205 | 0.94 | 3,681 | 0.82 | 21,256 | 4.74 |
East North Central | 3,151 | 0.90 | 2,610 | 0.74 | 12,366 | 3.37 |
West North Central | 428 | 0.94 | 365 | 0.68 | 1,199 | 3.03 |
South Atlantic | 3,380 | 0.80 | 2,733 | 0.63 | 15,309 | 3.63 |
East South Central | 1,192 | 0.81 | 867 | 0.58 | 5,129 | 3.30 |
West South Central | 2,749 | 0.94 | 1,951 | 0.68 | 15,800 | 5.25 |
Mountain | 1,105 | 0.74 | 1,032 | 0.68 | 5,970 | 3.77 |
Pacific | 3,996 | 0.90 | 3,506 | 0.79 | 26,724 | 5.94 |
Overall | 21,578 | 0.88 | 17,844 | 0.72 | 109,640 | 4.23 |
aAll races are non-Hispanic.